Daiichi Sankyo Company, Limited is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 1,148.2 billion in revenue in 2013. The company owns the American biotechnology company Plexxikon, the ... Daiichi Sankyo, Inc. (DSI) began operating in the U.S. in 2006.


Daiichi Sankyo is a global pharmaceutical company with its corporate origin in Japan.


Daiichi Sankyo, About Us, Company Profile, Company information. ... American Regent, Inc. (United States) .... Daiichi Sankyo (China) Holdings Co., Ltd.


As the U.S. subsidiary of a global pharmaceutical innovator, Daiichi Sankyo, ... Carrie Ann Inaba Partners with Daiichi Sankyo, Inc. to Encourage Americans to ...


U.S. Corporate Headquarters. Daiichi Sankyo, Inc. 211 Mt. Airy Road Basking Ridge, NJ 07920-2311. Phone: 908-992-6400. Fax: 973-944-2645 ...


About Daiichi Sankyo, Inc. Products · Patient Assistance Program · Research & Development · News Releases · Responsibility · Contact Us · Careers.


Daiichi Sankyo, Inc. company research & investing information. ... Daiichi Sankyo , Inc. announced that they will report fiscal year 2018 results at 1:00 PM, US ...


Apr 18, 2016 ... PARSIPPANY, N.J. and EDISON, N.J., April 18, 2016 /PRNewswire/ -- Daiichi Sankyo, Inc., the U.S. subsidiary of Daiichi Sankyo Company, Ltd.


Mar 1, 2018 ... Daiichi Sankyo U.S. headquarters in Basking Ridge ... as of February 2017, citing QuintilesIMS data, with Injectafer holding a 30.9% share.